Suzuki N, Watanabe A
Jpn J Antibiot. 1985 Sep;38(9):2571-6.
Ten cases of bacterial infections, showing no or insufficient response to antibacterial chemotherapy, were treated with a new intravenous human gamma-globulin (SM-4300). SM-4300 was administered intravenously (68-172 mg/kg/day) once a day for 1-3 days. SM-4300 was effective in 6 out of 8 pneumonia cases and also in 1 out of 2 septicemia cases. In none of the 10 cases, any side effects were observed.
十例对抗菌化疗无反应或反应不足的细菌感染病例,接受了一种新型静脉用人γ-球蛋白(SM - 4300)治疗。SM - 4300静脉给药(68 - 172毫克/千克/天),每天一次,持续1 - 3天。在8例肺炎病例中有6例、2例败血症病例中有1例,SM - 4300治疗有效。10例病例均未观察到任何副作用。